NASDAQ · Biotechnology

Crispr Therapeutics AG (CRSP)

$54.00 -5.82%

Add alert

46 In band Daily RSI (14) · 6 Oct 2026

Moving averages

SMA 200$53.28+1.35%

Company profile

CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.

SectorHealthcare

IndustryBiotechnology

Market cap$5.00B

P/E ratioNone

EPS$-4.71

Beta1.76

Dividend yield0.00%

52-week high$78.48

52-week low$44.12

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 43 VRTX Vertex Pharmaceuticals Inc RSI 38 IOVA Iovance Biotherapeutics Inc RSI 66 MRNA Moderna Inc RSI 60 VKTX Viking Therapeutics Inc RSI 39 SRPT Sarepta Therapeutics Inc RSI 37 EDIT Editas Medicine Inc RSI 49 IBRX ImmunityBio Inc RSI 61 NVAX Novavax Inc RSI 60 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 63

Free forever

RSI alerts for CRSP

Get an email the moment Crispr Therapeutics AG crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 13 September 2026 at 2:19 AM EDT